Add like
Add dislike
Add to saved papers

Cross-linked ultra-high-molecular weight polyethylene liner and ceramic femoral head in total hip arthroplasty: a prospective study at 5 years follow-up.

BACKGROUND: Recent data indicate that enhanced wear resistance can be obtained with new cross-linked ultra-high-molecular weight polyethylene (CL-UHMWPE) liners, in comparison with previous-generation liners. The current prospective, cohort study was undertaken to analyse whether the use of a new CL-UHMWPE (Rexpol) results in a lower wear rate than ultra-high-molecular weight polyethylene (UHMWPE) in a group of similar patients undergoing total hip arthroplasty (THA). This study provides the first clinical data with this particular CL-UHMWPE.

METHODS: Between January 2001 and December 2001, patients underwent THA with biconical threaded cups and ceramic femoral heads using either a CL-UHMWPE liner (n = 50) or a regular UHMWPE liner (n = 57). At the time of the final 5-year evaluation, there were 48 patients available in the CL-UHMWPE and 54 patients available in the UHMWPE group.

RESULTS: After a mean 5.6 years follow-up, there were no significant differences between the groups in Harris Hip Score outcomes. However, there was a 69.1% decrease in wear at 5 years for the CL-UHMWPE group in comparison with the UHMWPE group (p < 0.01).

CONCLUSION: The use of CL-UHMWPE significantly reduced the risk of polyethylene wear in patients undergoing THA with biconical threaded cups and ceramic femoral heads. Further follow-up is needed to determine how this will influence long-term outcomes.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app